Fetal-neonatal alloimmune thrombocytopenia;Trombocitopenia aloinmune en el feto y en el recién nacido

Anales de Pediatria

Volumn 58, Issue 6, 2003, Pages 562-567

  Muniz Diaz E ^a,c   Ginovart Galiana, G ^b  

^a Banco de Sangre   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Alloimmune thrombocytopenia

Indexed keywords

ALLOANTIBODY; IMMUNOGLOBULIN G; THROMBOCYTE ANTIBODY; THROMBOCYTE ANTIGEN;

ALLOIMMUNITY; ANTIBODY DETECTION; BIRTH; BLEEDING; BRAIN HEMORRHAGE; CAUSE OF DEATH; CELL DESTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE SEVERITY; DRUG INFUSION; EARLY DIAGNOSIS; FETUS CELL; FETUS DISEASE; HUMAN; NEUROLOGIC DISEASE; NEWBORN DISEASE; PETECHIA; PREGNANCY; PRENATAL CARE; PROPHYLAXIS; PURPURA; RECURRENT DISEASE; REVIEW; RISK; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 0037829361     PISSN: 16954033     EISSN: None     Source Type: Journal    
DOI: 10.1157/13048090     Document Type: Review

References (39)

1. Kaplan C. Immune thrombocytopenia in the foetus and the newborn: Diagnosis and therapy. Transfus Clin Biol 2001;8: 311-4.
2. Williamsom LM, Hackett G, Rennie J, Palmer Ch, Maciver C, Hadfield R, et al. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PIA1, Zwa) as determined by antenatal screening. Blood 1998;92:2280-7.
3. Dreyfus M, Kaplan C, Verdy E, Schlegel N, Duran-Zaleski I, Tchernia G, et al. Frequency of iimune thrombocytopenia in newborns: A prospective study. Blood 1997;89:4402-6.
4. Murphy MF, Hambley H, Nicolaides K, Waters AH. Severe fetomaternal alloimmune thrombocytopenia presenting with fetal hydrocephalus. Prenatal Diagnos 1996;16:1152-5.
5. Stanworth SJ, Hackett GA, Williamsom LM. Fetomaternal alloimmune thrombocytoepnia presenting antenatally as hyclrops fetalis. Prenatal Diagnos 2001;21:423-4.
6. Kaplan C, Daffos F, Forestier F, Morel MC, Chesnel N, Tchernia G. Current trends in neonatal alloimmune thrombocytopenia: Diagnosis and therapy. En: Kaplan-Gouet C, Schlegel N, Salmon C, MacGregor J, editors. Platelet immunology: Fundamental and clinical aspects. London: John Libbey, 1991; p. 267-78.
7. Von dem Borne AEGKr, Décary F. Nomenclature of platelet-specific antigens. Transfusion 1990;30:477.
8. Santoso S, Kiefel V. Human platelet alloantigens: Update. Vox Sang 1998;74:249-53.
9. Lucas GF, Metcalfe P. Platelet and granulocyte glycoprotein-polymorphisms. Transf Med 2000;10:157-74.
10. Kelton JG, Smith JW, Horsewood P, Humbert JR, Hayward CP, Warkentin TE. Gova/b alloantigen system on human platelets. Blood 1990;75:2172-6.
11. Mueller-Eckhardt C, Grubert A, Weisheit M, Mueller-Eckhardt G, Kiefel V, Kroll H, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989;333:363-6.
12. a Descripción de los primeros casos detectados con la técnica de MAIPA. Biol Clin Hematol 1991;13:181-9.
13. Kaplan C, Morel-Kopp MC, Kroll H, Kiefel V, Schlegel N, Chesnel N, et al. HPA-5b(Bra) neonatal alloimmune thrombocytopenia: Clinical and immunological analysis of 39 cases. Br J Haematol 1991;78:425-9.
14. Glade-Bender J, McFarland J, Kaplan C, Porcelijn L, Bussel J. Anti-HPA3a induces severe neonatal alloimmune thrombocytopenia. J Pediatr 2001;138:862-7.
15. a, a new platelet antigen involved in two cases of neonatal alloimmune thrombocytopenia. Vox Sang 1986;50:177-80.
16. a) neonatal alloimmune thrombocytopenia. First report in a Caucasian family. Transf Med 1992;2:273-6.
17. a) in a Caucasian family. Transf Med 1993;3:164-5.
18. Martínez C, Muñiz-Díaz E, Puig N, Ibáñez M, Gracia M, Arilla M, et al. Neonatal alloimmune thrombocytopenia is still an immune diagnosis challenge. Transf Med 1998;8:87.
19. Parra R, Pérez-Anoro P, Gil J, Gala G, Calzada R, Gallardo D, et al. Neonatal alloimmune thrombocytopenia: immunological profile in 92 cases). Transf Med 1998;68:88.
20. Bordin JO, Kelton JG, Warner MN, Smith JW, Denomme GA, Warkentin TE, et al. Maternal immunization of the Gov alloantigen system on human platelets. Transfusion 1997;37:823-8.
21. Berry J, Murphy CM, Smith GA, Ranasinghe E, Finberg R, Walton J, et al. Detection of Gov system antibodies by MAIPA reveals an immunogenicity similar to the HPA-5 alloantigens. Br J Haematol 2000;110:735-42.
22. A1): association with HLA-DRw52 is not a 100%. Transf Mef 1992;2:251-3.
23. Murphy MF, Williamson LM. Antenatal screening for fetomaternal alloimmune thrombocytopenia: An evaluation using criteria of the U.K national screening committee. Br J Haematol 2000;111:726-32.
24. Von dem Borne AEGKr, Verheugt FWA, Oosterhof F, Von Riesz E, Brutel de la Rivière A, Engelfriet CP. A simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol 1978;39:195-207.
25. Kiefel V, Santoso S, Weisheit M, Mueeler-Eckhardt CM. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): A new tool for the identification of platelet reactive antibodies. Blood 1987;70:1722-6.
26. Lucas GF, Rogers SE. Evaluation of an enzyme-linked immunosorbent assay (GTI PakPlus) for the detection of antibodies against human platelet antigens. Transf Med 1999;9:63-7.
27. Kroll H, Kiefel V, Santodo S. Clinical aspects and typing of platelet alloantigens. Vox Sang 1998;74(Suppl 2):345-54.
28. Ouwehand H, Smith G, Ranasinghe E. Management of severe alloimmune thrombocytopenia in the newborn. Arch Dis Child Fetal Neonatal Ed 2000;83:F173-5
29. Ranasinghe E, Walton JD, Hurd CM, Saul L, Smith G, Campbell K, et al. Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia. Br J Haematol 2001;113:40-2.
30. Murphy MF, Knechtli C, Downie C, Rogers SE, Lucas GF. Serendepity and the use of random platelets in fetomaternal alloimmune thrombocytopenia (FMAIT). Br J Haematol 2001;113: 1077-8.
31. Muñiz-Díaz E, Parra J, Ginovart G, Martínez C, Ibáñez M, Gracia M, et al. Tratamiento antenatal de la trombocitopenia fetal/neonatal aloinmune con transfusión de plaquetas intraútero. Haematologica 2001;86(Supl 2):1.
32. Kaplan C, Daffos F, Forestier F, Cox WL, Lyon-Caen D, Dupuy-Montbrun MC, et al. Management of alloimmune thrombocytoepnia: antenatal diagnosis and in utero transfusion of maternal platelets. Blood 1988;72:340-3.
33. Murphy MF, Waters AH, Doughty HA, Hambley H, Mibashan RS, Nicolaides KH, et al. Antenatal management of fetomaternal alloimmune thrombocytopenia-report of 15 affected pregnancies. Transfus Med 1994;4:281-92.
34. Bussel JB, Berkowitz RL, McFarland JG, Lynch L, Chitkara U. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Engl J Med 1988;319:1374-8.
35. Bussel JB, Berkowitz RL, Lynch L, Lesser ML, Paidas MJ, Huang CL, et al. Antenatal management of alloimmune thrombocytopenia with intravenous gammaglobulin: A randomized trial of the addition of low dose sterorid to IVIg in fifity-five maternal-fetal pairs. Am J Obstet Gynecol 1996;174:1414-23.
36. Kroll H, Kiefel V, Giers G, Bald R, Hoch J, Hanfland P, et al. Maternal intravenous immunoglobulin treatment does not prevent intracranial hemorrhage in fetal alloimmune thrombocytopenia. Transfus Med 1994;4:293-6.
37. Kaplan C, Murphy MF, Kroll H, Waters AH. Feto-maternal alloimmune thrombocytopenia: Antenatal therapy with IvIgG and steroids-more questions than answers. Br J Haematol 1998;100:62-5.
38. Zimmerman R, Huch A. In utero fetal therapy with immunoglobulin for alloimmune thrombocytopenia. Lancet 1992;340: 606.
39. Doughty HA, Murphy MF, Metcalfe P, Waters AH. Antenatal screening for fetal alloimmune thrombocytopenia: The results of a pilot study. Br J Haematol 1995;90:321-5.